『Still Flashing at 65? You’re Not Too Late for HRT』のカバーアート

Still Flashing at 65? You’re Not Too Late for HRT

Still Flashing at 65? You’re Not Too Late for HRT

無料で聴く

ポッドキャストの詳細を見る

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

In this episode I break down one of the most frustrating myths I hear in women’s health: that once you reach a certain age — usually 60 or 65 — you’re “too old” to start hormone therapy.

Spoiler alert: that is not true. And it’s long overdue that we challenge the outdated thinking behind it.

I walk you through how this myth started, what the science actually shows, and how a personalized, risk-based approach is what really matters — not your birthday.

Key Topics I Cover:
  • Where the “Too Old” Myth Started: The 2002 WHI study caused panic, but it was never designed to assess quality of life — and its flawed conclusions about age cutoffs still haunt modern care.
  • The Real Impact of Stopping HRT After 60: Many women were forced off therapy overnight, leading to a resurgence of symptoms and long-term confusion among providers.
  • The Truth About Vasomotor Symptoms (Hot Flashes & Night Sweats):
    • Can last 7–14 years or more
    • Up to 1 in 3 women over 65 still suffer from them
    • More severe and long-lasting in African American and Hispanic women
  • Other Menopausal Syndromes That Persist or Worsen With Age:
    • Genitourinary Syndrome of Menopause (GSM): Dryness, pain with sex, urinary symptoms
    • Musculoskeletal Symptoms: Joint pain, frozen shoulder, hand stiffness
    • Sleep Disruption: Even without night sweats, quality of sleep drops significantly
    • Cognitive Decline: Brain fog, word-finding issues, memory trouble — not just “getting older”
  • Why There’s No Magical Cutoff at Age 60 or 65: Menopause isn’t a finish line — it’s a transition. And most women spend 30–40 years post-menopause. We can’t ignore their needs for half their lives.
  • What New Data Actually Shows:
    • Later follow-ups (13+ years) from WHI show no increased risk of heart disease or death in women 60+ on HRT
    • Slight increases in stroke and clot risk only apply to oral estrogen — not safer, modern non-oral methods
    • Estrogen-alone therapy may reduce risk of dementia-related death
    • Cognitive data still evolving — but timing, route, and type of hormone matter
  • Why a Personalized Risk-Benefit Approach Is Critical: Your chronological age isn’t enough. I look at:
    • Bone density
    • Heart and brain health
    • Sleep quality
    • Symptom burden
    • Family history
  • Final Takeaway: If you're being told you can't continue or start hormones because of your age — challenge it. Ask why. And if your provider can’t answer, find one who can.

Follow us!

Instagram https://www.instagram.com/foundationskristinjacksonmd/

Website https://www.foundationsfl.com/

FB facebook.com/advancedurogynecology

まだレビューはありません